Recruiting
Scleroderma associated digital ulcer
RecruitingRegistered drug
Study on the Safety of TOP-N53 for Treating Digital Ulcers in Systemic Sclerosis Patients
Registered drug
- Disease:Scleroderma associated digital ulcer
- Substances:Sildenafil Citrate2-[1-(3-{6-[(1E)-(Hydroxyimino)Methyl]-5-Methyl-4-Oxo-7-Propyl-3H,4H-Pyrrolo[2,1-F][1,2,4]Triazin-2-Yl}-4-Propoxybenzenesulfonyl)Piperidin-4-Yl]Ethyl Nitrate
Countries:
France
France- Participants:18–64 years · 65+ years
- Substances:Sildenafil Citrate
- Sponsor:Topadur Pharma AG
